What Do Analysts Say About OS Therapies Inc (OSTX)?

Rosalind Gate

OS Therapies Inc (OSTX) saw an uptrend of 6.94% in the recent trading with $1.54 being its most recent. The current price level -78.00% lower than the highest price of $7.00 marked by the stock while trading over the past 52-weeks, whereas it is 37.50% higher than the lowest price of $1.12 the company dropped to over past 52-weeks. The latest news story on OSTX appeared in (Newsfile Corp.) under the title “OS Therapies Enters into Warrant Inducement Agreements”.

Do analysts rate it as a buy, sell or hold?

Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.

OS Therapies Inc Earnings – What Happened With OSTX

Coming around sales and income figures on OSTX Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. OS Therapies Inc (OSTX) last released financial results for the quarter that ended 12/31/2024, posting a surprise factor of -71.43% for net revenue.

OSTX – OS Therapies Inc Stock Earnings Estimates

The perspective of OS Therapies Inc (AMEX:OSTX)’s current quarter earnings identifies that analysts are in consensus over the estimate of -0.14 for stock’s EPS in the current quarter. OS Therapies Inc (OSTX) last released financial results for the quarter that ended 12/31/2024, posting a surprise factor of -71.43% for net revenue. Company’s EPS for the last quarter was -0.24.

OS Therapies Inc – Insider Activity and Holdings

Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 33.27 million. OSTX does have institutional investors; and they hold 4.41% of the stock.

Key Metrics for OSTX

The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, OS Therapies Inc has a debt to equity ratio of 0.00.

Baxter Report
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.